|
 |
Drugs & Kaiser Foundation Health Plans, Inc NewsHealth Insurance & Drugs
> Drugs & Kaiser Foundation Health Plans, Inc
1 - 15 / 232 NEXT
 NOT SATISFIED WITH THIS DRUGS & KAISER FOUNDATION HEALTH PLANS, INC NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT
OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories. <<< Please read the disclaimer for more details.>>> |
 
Press Releases
• E-Vocabulary - On-line Language Tool for Hotel & Travel Industry [20 Aug 2008] • Article Published: "FACIS - Fact You Should Not Ignore" [19 Aug 2008] • Abstract Aquarium Backgrounds.com Changes the Blue Background [19 Aug 2008]
Business Directory
• Georgia and Russia: the Case Against a NATO Membership for Tbilisi (By Tracy Dove, the Naked Historian) [16 Aug 2008 - 21:06] • That Paris Hilton-Britney Spears-Barack Obama TV Ad Is Not a 'Race Card;' It's Just Flat Out Dangerous (Joe Rothstein's Commentary) [13 Aug 2008 - 11:23] • Obama, Clinton, And The Fly On The Wall (Joe Rothstein's Commentary) [06 Aug 2008 - 15:42] • Why Does The Bush Administration Have A Get-Out-Of-Jail-Free Card? (Joe Rothstein's Commentary) [30 Jul 2008 - 01:54] • Merck's Vioxx study 'a marketing ploy'Â [20 Aug 2008 - 07:38] • Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma [20 Aug 2008 - 06:28] • Researchers: Merck Vioxx Study Was for Marketing - August 19, 2008 [20 Aug 2008 - 05:32] • Researchers: Merck Vioxx study was for marketing [20 Aug 2008 - 05:15] • Merck Vioxx study was for marketing: researchers [20 Aug 2008 - 04:11] • FDA May Withdraw Accelerated Midodrine HCl Approval [20 Aug 2008 - 01:57] • Clinton FDA Used Norms in Abortion Pill Approval [19 Aug 2008 - 23:26] • SolarWorld CEO Denies GE Bid; GE Healthcare IT Unit Warned by FDA [19 Aug 2008 - 19:17] • FDA issues Byetta warning [19 Aug 2008 - 17:57] • Amylin stock sinks as FDA calls for stronger warning on Byetta [19 Aug 2008 - 16:50] Take This Poll• Clinical Trial Touches Off Drug Access Fight [20 Aug 2008 - 06:28] • Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma [20 Aug 2008 - 05:32] • Clinical Trials Update: Aug. 19, 2008 [20 Aug 2008 - 05:31] • AMRI initiates Phase I study of oncology drug [20 Aug 2008 - 03:17] • 12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis [20 Aug 2008 - 02:54] • Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma [20 Aug 2008 - 05:32] • Rituximab Promotes Healing in Common Kidney Disease [20 Aug 2008 - 05:16] • Actavis wins US approval for generic Wellbutrin XL 300mg [20 Aug 2008 - 03:17] • Cirrus Tech Updates Dedicated Server Hosting Plans [19 Aug 2008 - 23:01] • Firms Conclude Deal in Lipitor Patent Case [19 Aug 2008 - 21:52] • Logical reports positive results from Phase Ib naproxen prodrug study [20 Aug 2008 - 03:17] • Inside health: Death toll casts new doubts on methadone [20 Aug 2008 - 03:14] • Inside health: Death toll casts new doubts on methadone [20 Aug 2008 - 01:56] • Inside health: Death toll casts new doubts on methadone [20 Aug 2008 - 00:32] • Unichem Lab Gets FDA Approval for Hydrochlorothiazide Tablets [19 Aug 2008 - 23:26] • Unichem Lab Gets FDA Approval for Hydrochlorothiazide Tablets [19 Aug 2008 - 23:26] • Unichem Laboratories gets USFDA nod for Hydrochlorothiazide tablets [19 Aug 2008 - 22:15] • Unichem Lab gets USFDA approval for Hydrochlorothiazide tab [19 Aug 2008 - 12:55] • Unichem Lab. Gets US FDA Approval For Hydrochlorothiazide Tabs [19 Aug 2008 - 10:26] • India's Unichem Labs gets U.S. FDA approval for hydrochlorothiazide tablets [19 Aug 2008 - 09:32] • Merck's Vioxx study 'a marketing ploy'Â [20 Aug 2008 - 07:38] • Vioxx drug study was devised by marketing men, report claims [20 Aug 2008 - 07:02] • Researchers: Merck Vioxx Study Was for Marketing - August 19, 2008 [20 Aug 2008 - 05:32] • Researchers: Merck Vioxx study was for marketing [20 Aug 2008 - 05:15] • Merck Vioxx study was for marketing: researchers [20 Aug 2008 - 04:11] • Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma [20 Aug 2008 - 05:32] • A Case of Left Urothelial Carcinoma with Multiple Bone Metastasis, Liver Metastasis and Right Adrenal Metastasis Successfully Treated with Combination Chemotherapy of Gemcitabine and Carboplatin [20 Aug 2008 - 05:16] • Rituximab Promotes Healing in Common Kidney Disease [20 Aug 2008 - 05:16] • Zoledronic Acid Protects Bones of Women Getting Breast Cancer Treatment [20 Aug 2008 - 01:31] • Zoledronic Acid Protects Bones of Women Getting Breast Cancer Treatment [20 Aug 2008 - 00:55] • Firms Conclude Deal in Lipitor Patent Case [19 Aug 2008 - 21:52] • Higher dose of Pfizer's Lipitor may reduce risk of heart attack [19 Aug 2008 - 19:53] • Abbott and AstraZeneca to co-promote Crestor [19 Aug 2008 - 02:33] • Schering-Plough, Merck's Vytorin misses study goal [18 Aug 2008 - 23:48] • Abbott and AstraZeneca to co-promote Crestor [18 Aug 2008 - 17:07] • Amylin Takes Hit After Two Deaths Are Linked to Byetta [20 Aug 2008 - 00:46] • Amylin Takes Hit After Two Deaths Are Linked to Byetta [20 Aug 2008 - 00:34] • U.S. seeks warnings for Amylin diabetes drug [20 Aug 2008 - 00:17] • CORRECTED: U.S. seeks warnings for Amylin diabetes drug [19 Aug 2008 - 23:32] • CORRECTED-UPDATE 2-US seeks warnings for Amylin diabetes drug [19 Aug 2008 - 23:32] • Rifamycin antibiotics attack tuberculosis bacteria with walls, not signals [20 Aug 2008 - 00:35] • Rifamycin antibiotics attack tuberculosis bacteria with walls, not signals [19 Aug 2008 - 21:51] • AMIDINOANTHRACYCLINE ANTIBIOTICS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS [19 Aug 2008 - 03:29] • Read Long Ordeal with Levaquin [19 Aug 2008 - 01:28] • Another Levaquin Lament [19 Aug 2008 - 01:28] • Aurobindo Pharma gets tentative approval for Efavirenz tablets [19 Aug 2008 - 22:15] • Next generation first-line NNRTI, rilpivirine (TMC278) potent; lowest dose better-tolerated than efavirenz at 96 weeks [19 Aug 2008 - 16:00] • METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPY [19 Aug 2008 - 03:29] • Gardasil vaccines [19 Aug 2008 - 02:29] • Gardasil Suspected in Australian Pancreatitis Cases [18 Aug 2008 - 15:30] |
|
wsj.com:
bloomberg.com:
nytimes.com: